Related Experiment Video
Updated: Apr 26, 2026

Using the Overlay Assay to Qualitatively Measure Bacterial Production of and Sensitivity to Pneumococcal Bacteriocins
Published on: September 30, 2014
Bactericidal effect of bovine lactoferrin and synthetic peptide lactoferrin chimera in Streptococcus pneumoniae and
Nidia León-Sicairos1, Uriel A Angulo-Zamudio, Jorge E Vidal
1Unidad de Investigación, Facultad de Medicina, Universidad Autónoma de Sinaloa, Cedros y Sauces, Fracc. Fresnos., C.P. 80246, Culiacán, Sinaloa, Mexico, nidialeon@uas.edu.mx.
Bovine lactoferrin (bLF) and a chimeric peptide (LFchimera) show bactericidal effects against Streptococcus pneumoniae. These agents also reduce bacterial virulence by down-regulating key genes, offering potential for new pneumococcal infection treatments.
Area of Science:
- Microbiology
- Immunology
- Biochemistry
Background:
- *Streptococcus pneumoniae* (pneumococcus) causes nearly one million child deaths annually from infections like pneumonia and meningitis.
- Lactoferrin (LF) is an antibacterial protein in the human immune system, but its efficacy against pneumococcus requires further study.
Purpose of the Study:
- To evaluate the bactericidal activity of bovine lactoferrin (bLF) and synthetic lactoferrin-derived peptides against *S. pneumoniae*.
- To investigate the mechanism of bacterial damage and the impact on virulence gene expression.
Main Methods:
- Treatment of *S. pneumoniae* planktonic cells with bLF and LF-peptides.
- Assessment of cell viability (CFU/ml), interaction via confocal microscopy and flow cytometry, structural damage via electron microscopy, membrane permeabilization, and gene expression (qRT-PCR).
Main Results:
- bLF and LFchimera demonstrated significant bactericidal effects.
- Interaction with bacteria caused morphological changes and membrane permeabilization.
- LF treatment led to down-regulation of the *luxS* gene, a key virulence factor.
Conclusions:
- bLF and LFchimera exhibit potent bactericidal activity against *S. pneumoniae*.
- LF and LFchimera disrupt bacterial cell structure and membrane integrity.
- LF's ability to down-regulate virulence genes highlights its potential as a novel therapeutic agent for pneumococcal infections.
More Related Videos
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
10:13Production and Visualization of Bacterial Spheroplasts and Protoplasts to Characterize Antimicrobial Peptide Localization
Published on: August 11, 2018
Related Concept Videos
Inhibitors of Gram-positive Cell Wall Synthesis
Clinical Significance of Antibiotic Resistance
Gene Regulation in Microbial Communities: Quorum Sensing
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Inhibitors of Bacterial Protein Synthesis
Mechanism of Antibiotic Resistance in MRSA